Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Inside-Out Approach Breaches Occluded Central Veins

By HospiMedica International staff writers
Posted on 19 Sep 2016
A novel arteriovenous (AV) access system facilitates central venous catheter (CVC) insertion via an inside-out approach.

The Bluegrass Vascular (San Antonio, TX, USA) Surfacer System is designed to reliably, efficiently, and repeatedly gain central venous access by first inserting it through the femoral vein, and navigating up through the patient's venous system to an exit point in the right internal jugular (RIJ) vein. The introducer sheath of the CVC is then locked onto the needle wire and pulled into the right atrium, using the Surfacer as its guide. The inside-out approach thus achieves access to an occluded RIJ vein, while preserving secondary central veins.

While permanent vascular access, such as an AV fistula, is the preferred access option for patients on hemodialysis therapy, these often can take four months or longer to mature, and a CVC is often required during this time period; unfortunately, more than 40% of these patients develop a venous obstruction. The Surfacer system can therefore safely provide the time needed for AV fistula maturation, thereby reducing hemodialysis provider cost due to CVC occlusion, and decreasing catheter-associated morbidity and other complications.

“The launch of the Surfacer System in Europe brings a much-needed solution to a growing population of patients requiring vascular access for vital treatments, and who currently have limited options due to obstructed upper body access,” said Gürkan Sengölge, MD, of the Medical University of Vienna (Austria; www.meduniwien.ac.at). “No other device offers such an innovative inside-out method for restoring access and preserving options in patients with chronically occluded veins.”

“Multiple central venous occlusions can cause significant long-term morbidity,” said John Gurley, MD, an interventional cardiologist at the University of Kentucky Medical Center (Lexington, USA), and founder of Bluegrass Vascular. “The novel inside-out approach is an innovative and simple method that restores and preserves right-sided venous access, despite chronic occlusion, and retains the viability of other existing central veins.”

An AV fistula is currently the most recommended access for kidney disease patients who must undergo dialysis, created by connecting a patient's vein and artery to form a long-lasting treatment site through which blood can be removed and returned. Many patients, however, prefer a catheter instead, for reasons that include inadequate preparation for dialysis, avoidance of surgery, or fear of needles (since the connection to the dialysis machine via a catheter does not require needles).

Related Links:
Bluegrass Vascular



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Aortic Valve Replacement System
INTUITY Elite
New
Automated Cough Assist Device
Bionic Cough Simulator
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.